What Characteristics at Baseline Are Associated with the Glucose-lowering Effect of Colestimide in Patients with Type 2 Diabetes and Hypercholesterolemia According to Response to Treatment?-Reference-Cited by-同舟云学术

What Characteristics at Baseline Are Associated with the Glucose-lowering Effect of Colestimide in Patients with Type 2 Diabetes and Hypercholesterolemia According to Response to Treatment?

Published:2013 Issue:3 Volume:80 Page:211-217
ISSN:1345-4676
Container-title:Journal of Nippon Medical School
language:en
Short-container-title:J Nippon Med Sch

Author:

Suzuki Tatsuya¹,Tsunoda-Kubota Misako¹,Aoyama Junya¹,Futami-Suda Shoko¹,Hashimoto Masao¹,Igari Yoshimasa¹,Watanabe Kentaro¹,Kigawa Yoshiaki²,Nakano Hiroshi¹,Oba Kenzo¹

Affiliation:

1. Department of Cardiovascular Medicine, Nippon Medical School

2. Hanno Geriatric Hospital

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jnms/80/3/80_211/_pdf

Reference25 articles.

1. 1. Oikawa S, Kita T, Mabuchi H, et al.: Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: Implication from Japan Lipid Intervention Trial (J-LIT). Atherosclerosis 2007; 191: 440-446.

2. 2. Brensike JF, Levy RI, Kelsey SF, et al.: Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation 1984; 69: 313-324.

3. 3. Garg A, Grundy SM: Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial. Ann Intern Me 1994; 15: 416-422.

4. 4. Zieve FJ, Kalin MF, Schwartz SL, et al.: Results of the glucose-lowering effect of Welchol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of cplesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin Ther 2007; 29: 74-83.

5. 5. Suzuki T, Oba K, Futami S, et al.: Blood glucose-lowering activity of colestimide in patients with type 2 diabetes and hypercholesterolemia: A case-control study comparing colestimide with acarbose. J Nippon Med Sch 2006; 73: 277-284.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bile acids and microbes in metabolic disease;World Journal of Gastroenterology;2022-12-28

2. Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications;Progress in Polymer Science;2018-12

3. The effects of bile acid sequestrants on lipid profile and blood glucose concentrations: A systematic review and meta-analysis of randomized controlled trials;International Journal of Cardiology;2017-01